Your browser doesn't support javascript.
loading
Data Analysis for Anti-Neoplastic Chemotherapy-Related Adverse Events Reported to the Korean Pharmacovigilance Regional Network / 대한내과학회지
Korean Journal of Medicine ; : 385-395, 2013.
Artículo en Coreano | WPRIM | ID: wpr-142777
ABSTRACT
BACKGROUND/

AIMS:

To describe the toxicity profile of anti-neoplastic agents from real clinical settings, we analyzed spontaneously reported adverse events (AEs) using data from the adverse drug reaction (ADR) reporting system of the Korean Food and Drug Administration (KFDA).

METHODS:

Data were extracted from the nationwide spontaneous ADR reporting system of KFDA from July 2009 to December 2010. We extracted and analyzed data related to chemotherapy and identified unlabeled ADR that were not described in the package insert of the products.

RESULTS:

In total, 5,867 cases of antineoplastic agent-related AE reports were identified after excluding cases for duplication and cases assessed as 'unlikely' and 'unclassifiable', based on expert opinion. Of the patients with AEs, 52.4% were males and the median age was 56 years. In total, 460 AEs (7.8%) from 267 patients were reported as 'serious' AEs. The most common causative anti-cancer drug class was pyrimidine analogs (31.5%), followed by platinum compounds (19.9%), protein kinase inhibitors (10.8%), and taxanes (8.8%). The most common clinical manifestation of AEs was gastrointestinal toxicities (25.5%), followed by skin disorders (25.3%), and generalized reactions (14.3%). In total, 168 cases (2.9%) of unlabeled AEs were identified. Among these, 10 were reported as serious AEs.

CONCLUSIONS:

The most common causative class of antineoplastic agents was that of pyrimidine analogs. Gastrointestinal and dermatological toxicities were the most common clinical chemotherapy-related adverse events. Further investigation and monitoring to evaluate causality associated with unlabeled AEs identified in this analysis are needed.
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Etiquetado de Productos / Pirimidinas / Piel / United States Food and Drug Administration / Estadística como Asunto / Compuestos de Platino / Taxoides / Inhibidores de Proteínas Quinasas / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Testimonio de Experto Límite: Humanos / Masculino Idioma: Coreano Revista: Korean Journal of Medicine Año: 2013 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Etiquetado de Productos / Pirimidinas / Piel / United States Food and Drug Administration / Estadística como Asunto / Compuestos de Platino / Taxoides / Inhibidores de Proteínas Quinasas / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Testimonio de Experto Límite: Humanos / Masculino Idioma: Coreano Revista: Korean Journal of Medicine Año: 2013 Tipo del documento: Artículo